All Activity

Your perspective on this topic is both unique and enlightening. This piece provides a fresh and compelling take on the subject. pips nyt

Your perspective on this topic is both unique and enlightening. This piece provides a fresh and compelling take on the subject. pips nyt

They understand that luxury is ultimately about feeling seen, heard, and valued without condition. The women offering Escort Service In Delhi & Delhi NCR have made this their life's work, creating sanctuaries of acceptance within the city's relentless pace. Their clients often speak of the profound relief of spending time with someone who asks nothing but their authentic presence, who listens without judgment to stories they've never shared, who holds them through vulnerability without requiring explanation. This unconditional acceptance creates an intimacy that transcends the physical, touching something far deeper in the human soul. Escort Dwarka || East Delhi Escort Service || Escorts East Of Kailash || Escorts in Faridabad || Escorts Service in Friends Colony || Escort Service Gandhi Nagar || Escort Geeta Colony || Greater Kailash Escort || Escorts Delhi Cantoment || Green Park Escorts ||

I visit your blog regularly and recommend it to all of those who wanted to enhance their knowledge with ease. The style of writing is excellent and also the content is top-notch. Thanks for that shrewdness you provide the readers! hargatoto

Wow, cool post. I’d like to write like this too – taking time and real hard work to make a great article… but I put things off too much and never seem to get started. Thanks though. slot 1000

I am jovial you take pride in what you write. It makes you stand way out from many other writers that can not push high-quality content like you. hargatoto

Escaping the pressures of business or travel often requires the soft touch of a woman who knows what she is doing. By opting for a reputable Call Girls Service In Mumbai, you open the door to a world of erotic possibilities. The women available are carefully selected for their beauty and their bedroom skills. They are affectionate, talkative, and incredibly sensual, ensuring that from the moment they step in, the atmosphere shifts to one of intimate comfort and raw sexual energy, leaving you feeling rejuvenated. 9

“There’s a part of me that my heart’s dancing because we are so much closer. So there’s more gratitude right now than anything.” By Anna Barrett, Alabama Reflector The Montgomery location of Callie’s Apothecary does not look like much. But standing on the concrete floors and surrounded by metal beams, owner Vince Schilleci described how the “pharmacy-adjacent” storefront will look. And when Callie’s opens—which Schilleci thinks could happen as early as April—it will likely be the first place in Alabama one can purchase legal medical cannabis. “We’ll have someone come and check in, scan the card to make sure you are an actual patient that’s been recommended medical cannabis,” he said. “For privacy, you have to wait out here until you can come on to the sales floor. Our goal is to get people in and out as quick as possible, because it’s a safety thing. We don’t want people loitering.” The opening could be milestone, nearly five years after the Legislature passed a law authorizing medical cannabis and following years of litigation and thwarted licensing processes. Amanda Taylor, a medical cannabis patient advocate, has been a part of the commission’s process since 2021. She has multiple sclerosis with 45 lesions on her brain and one on her spine. She welcomes the openings, but said in an interview Thursday that the delays took a toll. “There’s a part of me that my heart’s dancing because we are so much closer. So there’s more gratitude right now than anything,” Taylor said. “The suffering, the undue suffering that the patients had to endure because of the lawsuits, that kept this away from the patients.” Licenses The Alabama Medical Cannabis Commission (AMCC) has awarded three dispensary licenses, and Schilleci’s store, doing business as CCS of Alabama, is expected to be the first to open, according to AMCC General Counsel Justin Aday. “I don’t think that anybody’s dragging their feet. There’s a lot of balls in the air with different stakeholders at work,” Aday said. CCS; GP6 Wellness, based in Birmingham, and Montgomery-based RJK Holdings received licenses in December. A fourth dispensary license is yet to be distributed, but is likely to go to Yellowhammer Dispensaries, according to Aday. The commission delayed issuing Yellowhammer’s license in December due to litigation, but Aday said the commission requested an expedited decision, and hopes it will resolve soon. Once it does, there will be 12 dispensaries in the state. Schilleci said two other Callie’s Apothecary locations will open in a few months: one in Talladega, and one in Bessemer following a last minute location change from Cullman. Schilleci said in an interview last month that the company was able to take more business risks because it was not challenged during the licensing process. “We invested in a lot of equipment so we would be ready to go once we had the license in hand rather than ordering them,” Schilleci said. “We kind of gambled a little bit by spending money before we had the license in hand, but we felt good about things.” A dispensary is not a pharmacy, so the employees there will not be able to give medical advice, Schilleci said. But the dispensary will have a consultation room in case patients have questions about the products they have been recommended by board-certified physicians, a prerequisite for getting medical cannabis. As of last Friday, there were 20 physicians certified to recommend medical cannabis to patients in Alabama, according to the Alabama Board of Medical Examiners. Aday said in an interview Wednesday that about nine of the certified physicians registered through the commission’s patient registry. “I think it would be odd for them to go through the process with the board of medical examiners to not then use that certification,” Aday said. Physicians will not prescribe medical cannabis. Instead, they will recommend a product they believe will work for a patient with a qualifying condition, including cancer, depression, Parkinson’s Disease, post-traumatic stress disorder (PTSD), sickle-cell anemia, chronic pain and terminal diseases. The approved product forms are restricted to tablets, tinctures, patches, oils and gummies (only peach flavor), with raw plant material and smokable forms remaining prohibited. Each qualifying patient will have to register with the commission in order to get a recommendation from a physician and to receive a cannabis product from a dispensary. “We want them to be confident that not only we’re going to be professional and serve our customers, we’re also being compassionate, because these are people with ailments that are tough,” Schilleci said. “This isn’t a retail business. Yes, it’s retail, but it’s something more. It’s a call to serve at the end of the day.” Litigation has held up access to medical cannabis. Some firms sued the commission for not being awarded a license, citing a discriminatory process. Another case involved five parents that sued the commission over delays in access to cannabis, which was dismissed in August. Who will participate? As of last Friday, there were fewer than 10 patients registered for medical cannabis, and Aday said that it is hard to estimate how many patients will benefit from the program. Schilleci knew the process of getting product in patients’ hands would take a while, but said he was thankful it is ending soon. “For the patients, they’ve been waiting too long, it’s time for us to get this product to them,” Schilleci said. “I can’t get over it. It’s amazing how many folks are calling already saying, ‘Hey, when are you open? We’re ready for this.’” Taylor said in an interview that through her work as a patient advocate she has received over 700 emails from Alabamians, but patients will contact her through text, phone calls and social media, too. “It can be overwhelming, but at the same time, if there are days with my illness that I can’t really get around a lot, so I can devote time because I can’t really do anything else,” she said. Even though the nearly five year journey to get medical cannabis is nearing an end, Taylor said it has been exhausting. “I just want to say that no matter how you look at it, it’s a victory for the patients,” she said. “I can’t wait to celebrate for the patients.” Dispensary Locations: CCS of Alabama, LLC Montgomery, Bessemer and Talladega GP6 Wellness, LLC Birmingham, Athens and Attalla RJK Holdings, LLC Oxford, Daphne and Mobile Yellowhammer Medical Dispensary, LLC *pending license approval Birmingham, Owens Cross Roads and Demopolis This story was first published by Alabama Reflector. The post Alabama Medical Marijuana Sales Near Launch After Years Of Delay appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“People don’t know what the rules are. They don’t know what is in effect at a certain time… There is overall confusion around regulations, and that is the biggest issue.” By Stephen Simpson, The Texas Tribune Dallas attorney Chelsie Spencer specializes in making sure Texas businesses that sell hemp-derived THC products know how to stay in compliance with state and federal rules and regulations, an area that can be very confusing. She offers them a monthly service where her law firm rigorously vets distributors and helps to independently test their products to ensure they are safe and legal to sell in her clients’ stores. “They pay us a phenomenal amount to stay compliant,” Spencer said. That is why when Spencer learned that one of her North Texas clients had been raided by local police and the Drug Enforcement Administration, and his home surrounded, like he was a major narcotics dealer, she was shocked. “They took everything from my client…his children’s cellphones, every computer in the house, took all the vehicles, seized all assets, and froze all cash,” Spencer said of the raid that occurred in July. Since August 2024, local and federal law enforcement agencies have raided more than 15 businesses across the state that were accused of selling consumable hemp products that had illegal levels of THC, according to attorneys for these cannabis retailers. During these raids, law enforcement officials seized products and cash that businesses have still not recovered, and customers were scared away. Many of those retailers have not yet been found guilty of any crime, according to their attorneys. “You always see the headlines about the raids, but you never see these huge headlines about charges and indictments,” said Andrea Steel, a Houston attorney for several THC businesses. Even though they have affected a small fraction of 8,000 hemp retailers registered in Texas, these raids by law enforcement agencies have ramped up over the last two years to help some lawmakers build public support for banning hemp-derived THC products, Steel said. Over the summer, Gov. Greg Abbott (R) vetoed a bill the Legislature passed to ban hemp-derived THC and told state agencies to better regulate those THC products instead. But, she said her clients fear these types of raids will continue because the new regulations being considered could create THC limits that will be nearly impossible to meet, shuttering THC businesses and deterring businesses from selling THC products. “The same number of raids are occurring after the veto as before. In fact, there will likely be an increase in raids once the new rules and regulations are finalized because one of them is an increase in licensing fees for enforcement; they are going to need to justify that,” she said. Law enforcement agencies deny that these raids were politically motivated. They have said these raids were based on concerns that these retailers were selling dangerous products, especially to children, and engaging in other unscrupulous activities such as money laundering, according to a news conference from Allen police, as well as a joint one between Temple and Belton police departments. Allen Police Chief Steve Dyes, whose department raided at least a dozen businesses and warehouses since 2024, was a fixture at the Texas Capitol during the legislative session, warning lawmakers that the hemp industry was corrupt and couldn’t be trusted. “You have to have a trustworthy industry partner to regulate to know when they put something in a package, it matches the label. We just don’t have that with the THC consumables industry,” Dye said in September after Abbott vetoed the hemp ban and made an executive order for rules and regulations. Sammy Rippamonti, spokesperson for the Allen Police Department, said the investigation associated with the raids is still ongoing, and couldn’t provide further details. Dye did not respond to a request for comment. “The Temple Police Department does not conduct enforcement actions based on political developments or media narratives,” said Sydney McBride, spokesperson for the Temple Police Department, which raided seven businesses in June. “Our operations are driven by facts, evidence, and current applicable law. Our focus remains to work in partnership with the community to prevent, reduce, and solve crimes.” Multiple retailers have sued law enforcement agencies after these raids, alleging they are using a faulty testing method in their crime labs that artificially inflates the amount of THC in their products. Law enforcement agencies have defended their results. Data provided from the Texas Poison Center Network confirms a sharp increase in cannabis-related poisoning calls starting in 2019, a year after hemp-derived THC was legalized by the federal government, from 923 to a 10-year high of 2,592 in 2024, although those calls dropped last year to 1,485. The majority of these calls involve suspected poisoning of children under the age of five and teenagers. The Texas Department of State Health Services recently published a set of proposed rules to tighten regulations on consumable hemp products, including new testing requirements that industry members say will eliminate the use of hemp flowers, which is used in many THC products. Hemp businesses worry that this new requirement will be used as another reason to raid them. That, coupled with a proposal to hike licensing fees by more than 13,000 percent, will force many of them out of business, essentially fulfilling the desires of those who wanted to ban them, businesses say. “People don’t know what the rules are. They don’t know what is in effect at a certain time. I can’t tell you how many people thought that hemp got outlawed several months ago,” said Steel, who spoke recently at the Texas Cannabis Policy Conference, where increased police raids became a focus of discussion. “There is overall confusion around regulations, and that is the biggest issue.” Caught in political storm Spencer said last year’s raid saddled her client with crippling legal fees, disrupted revenue, and damaged his reputation. “We heard a lot of posturing saying we know what these people are doing, they’re sending money back to the Middle East. The district attorney is giving all these threats, saying these guys are going to jail, then 60 days in, we get a call saying come get all your stuff, take it back. We’re not moving forward,” she said. “We spent over $100,000 to get there.” In August 2024, Allen police and partnering agencies raided nine hemp shops, prompting the Hemp Industry Leaders of Texas to sue, alleging that those law enforcement agencies illegally seized lawful inventory. The organization accused law enforcement in the lawsuit of aggressively harassing and intimidating retailers, including being told that the city was going to rezone certain areas in a manner that would prohibit hemp-related businesses. Although the lawsuit is still tied up in federal court, the Allen Police Department, supported by the DEA, in July raided three warehouses, seizing more than 75,000 pounds of THC products and an estimated $7 million in cash and assets. When asked by CBS News Texas, which Dye invited to cover the raid, if these raids were timed to pressure Abbott to allow the bill creating a ban to go into effect, Dye denied any connection. However, the news organization noted Dye headed straight to Austin after the raid to meet with Abbott’s staff about the ban. The DEA department in Dallas told The Texas Tribune law enforcement agencies are still investigating their case against the businesses involved in the August 2024 and July 2025 raids, and no charges have been filed yet. Many of the raids over the last two years have resulted in lawsuits, and the hemp industry has had some success in obtaining some relief for businesses. Garza County Sheriff’s Office and the city of Post agreed to pay an $80,000 settlement to a Texas smoke shop in October 2024, after the owners accused law enforcement of conducting a “warrantless search.” The city and county insisted the settlement wasn’t an admission of wrongdoing, but rather to avoid the cost of litigation. State Rep. Drew Darby, a San Angelo Republican who once opposed hemp-derived THC but now supports it, told a room full of hemp businesses during the Texas Cannabis Policy Conference that he understands why politicians have a fear of THC products. He shared a story about a family friend whose grandchild became addicted to THC products. He also said rumors were circulating that these products were controlled by foreign enemies that seek to “infiltrate our country.” However, he knows that THC products can help elderly people with pain, children with epilepsy and seizures, and veterans with PTSD. He said lawmakers should focus on keeping these products legal and making them safer. “So we have to keep diffusing that talk and focus on the real issues,” he said. Testing and waiting Seven vape and smoke shops in Temple and Belton were also raided in mid-June 2025, with authorities seizing products they claimed were falsely labeled as legal hemp. Documents provided by the Temple Police Department state that the multi-agency investigation into these vape shops involved purchasing and testing items from these stores, where the “flower” product, such as joints, tested above the legal limit for THC. Six of the shop owners were charged with manufacture or delivery of a controlled substance, and one shop owner was charged with manufacture, delivery, and possession of marijuana, five to 50 pounds. Temple police say these charges have not been adjudicated yet. Multiple lawsuits by hemp businesses allege these raids are based on faulty testing methods that the Texas Forensic Science Commission cautioned against in 2022. The commission says the method actually produces more THC than is in the product. “In other words, a plant or liquid item of evidence containing CBD can arrive at the laboratory with a certain amount of (Delta 9 THC), and that amount can be increased by high heat used in the testing process,” the commission stated in the report. These faulty testing methods have been used in private and public crime labs across the state, including those used by the Texas Department of Public Safety, according to the HILT lawsuit. McBride said that for its forensic analysis, the Temple Police Department utilizes laboratories operated by the Texas Department of Public Safety and laboratories approved by DPS. “We stand behind the laboratory results provided by DPS and its approved affiliate laboratories,” she said. “ Enforcement decisions are made based on the totality of the evidence, including verified forensic findings.” Peter Stout, president and chief executive officer for the Houston Forensic Science Center, agrees that many crimes labs across the state don’t have a good method right now to test THC levels, but they also don’t have enough funding for training on how to do proper testing and more importantly, they don’t have the time to test cannabis, which is often associated with lower level crimes. “I can’t with a straight face justify all the costs associated with standing up the capacity to test everything that law enforcement might seize from a dude on the street corner with something green in his pocket. So, no, I am not going to test that. I am equipped with one analyst and one piece of equipment. We deal with it for the large felony kinds of cases,” he said at the cannabis conference. Stout said the counties that want to prosecute low level THC cases most likely will need to use independent laboratory testers, which can cost $10,000 for each test. However, many local prosecutors don’t have access to that kind of funding, and they send their evidence to the Texas Department of Public Safety crime lab, which is so backlogged that it can take months for the results to return. Some of those products that were raided get held up in crime lab testing, becoming inventory that these businesses can’t sell, which hurts their bottom line, Steel said. “I had a client whose business was raided; they seized a substantial portion of their inventory, disrupting their business, based on an outdated test,” she said. Preparing for the future When the state health department recently entered Martha Velez’s hemp retail store in Dallas to conduct an inspection, her staff was prepared. She had a binder prepared for everything the agency might be looking for that included certifications, compliance documents, and more and once they found nothing, the agency left. Her store has been visited multiple times by state agencies over the past two years, and each time it passed due to a level of preparation necessary in an industry under intense scrutiny of local law enforcement and state lawmakers. Velez said she feels a responsibility to ensure she protects her customers by going above and beyond normal business practices. “The raids in Dallas were hard for us. We decided to keep that mini binder that had excerpts highlighted, like what is the law in regards to flower? What is the law regarding the .3 percent?,” she said at the Texas Cannabis Policy Conference, referring to the legal amount of THC allowed in consumable hemp products. “Just to be prepared.” One of the inadvertent side effects of these raids has been the hemp industry starting to self police as they wait for new state regulations to be adopted. At the Texas Cannabis Policy Conference, there were panels on how to have documents ready for law enforcement, conduct background checks on products, protect oneself in court, and more. Steel expects that once the state finalizes regulations, there will be another spike in raids on hemp stores. She encouraged businesses to mitigate risk from future raids and regulatory changes by keeping inventory small. “Don’t keep something you can’t get rid of on short notice because there are just too many things changing rapidly,” she said. “You have to be ready to pivot.” Velez said that while the raids have been rough on the industry, there still seems to be an appetite among law enforcement and the hemp industry to understand each other, and if that can be accomplished, then the industry can thrive. “Funny thing was, we had this one big event, and there were like four officers there who talked to us the entire time, wanting to get educated,” she said. This article first appeared on The Texas Tribune. Photo courtesy of Max Jackson. The post Texas Could See A Spike In Raids On Hemp Businesses Under New Rules, Industry Advocates Fear appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

That is thus gorgeous and also imaginative. I recently really like the particular shades and also anyone who receives that inside the email will probably be beaming. iptv kopen

Thanks a lot for the purpose of rendering up to date update versions about the challenge, I just await read through further. https://rollsiptv.com/

The sponsor filed a motion to potentially revive the legislation for future reconsideration. By Barbara Hoberock, Oklahoma Voice Oklahoma House lawmakers on Thursday defeated a measure that would give employers more leeway to fire individuals for using medical marijuana. Rep. Kevin West, R-Moore, the author, said House Bill 3127 would not force employers to do anything, but would give them discretion to classify additional jobs as “safety-sensitive” beyond what is in law. State law allows businesses to prohibit employees from using marijuana who work in “safety-sensitive” jobs based on drug testing. Existing law classifies “safety-sensitive jobs” as those that require operating vehicles, machines and power tools, carrying a firearm and providing direct care to patients or children, among other duties. West said nothing in the bill says that if a person tests positive, they are out of a job. He said he would be shocked if employers began listing all jobs as “safety-sensitive.” If every business implemented classified every job as “safety-sensitive,” they would not be able to find individuals to hire, West said. Over 315,000 Oklahomans hold medical marijuana licenses, state records show. Critics cited concerns about the legality and the potential impact on employees who have a doctor’s prescription to legally use the drug. They argued existing law already has broad categories for “safety-sensitive” jobs and questioned the necessity of expanding it. Rep. Chris Kannady, R-Oklahoma City, said marijuana can stay in a person’s system for weeks. Rep. Erick Harris, R-Edmond, said that under the measure, he could fire his assistant for using medical marijuana. West said the assistant could not be fired for just having a medical marijuana card, but could be terminated if the employer classified the position as “safety-sensitive” and the employee in that job tested positive for marijuana Although the measure failed, West served notice that on some future legislative day he may bring the measure back up for another vote. This story was first published by Oklahoma Voice. Photo courtesy of Brian Shamblen. The post Oklahoma Lawmakers Reject Bill To Let Employers Fire More Workers For Using Medical Marijuana appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“For the patients that this program is designed to serve, it’s not always worked well enough. This bill is an effort to make sure that for the patients, this program works better.” By Maya Homan, Georgia Recorder A bill aimed at modernizing Georgia’s medical cannabis program passed the House with broad bipartisan support, marking another step in lawmakers’ years-long effort to incrementally increase patients’ access to the program. Senate Bill 220, introduced by Newnan Republican Sen. Matt Brass, would expand the conditions eligible to receive a medical cannabis card, change the limits on the amount of cannabis that someone can possess and enable patients to vape the product. It passed the House in a 138-21 vote. The changes made to the bill incorporate feedback from a House study committee that met last year to examine the issue, according to Rep. Mark Newton, an Augusta Republican who sponsored the bill in the House. In a speech shortly before Wednesday’s vote, he said updates to the program were needed to ensure that patients and providers can successfully navigate the program. “For the patients that this program is designed to serve, it’s not always worked well enough,” Newton said. “This bill is an effort to make sure that for the patients, this program works better.” Tetrahydrocannabinol, generally abbreviated to “THC,” is the psychoactive compound in marijuana that is currently classified as a Schedule I drug at the federal level, though the Trump administration is looking to loosen federal restrictions on marijuana to gain a better understanding of its potential medical benefits. Some studies have shown that THC’s non-psychoactive counterpart cannabidiol, also known as CBD and derived from the hemp plant, may be effective in treating health conditions like epilepsy, chronic pain and anxiety. Both compounds fall under the umbrella of medical cannabis, according to the Georgia Access to Medical Cannabis Commission, which administers the state’s program. Georgia law currently mandates that medical cannabis products must not contain more than 5 percent THC. The version of the bill that passed the Senate would have raised that cap to 50 percent, but House lawmakers ultimately decided to switch from a percentage cap to a 12,000 milligram limit, which Newton said is aimed at ensuring Georgia’s regulations better reflect doctors’ prescribing practices. “There are other delivery methods, other ways of delivering this medical cannabis, that are more aligned with the way we practice medicine in every other field,” Newton, who is an emergency medicine doctor, said. The bill also adds a provision allowing patients over the age of 21 to vape medical cannabis, which was not previously allowed under Georgia law. Advocates had argued that patients with seizures and other conditions needed greater access to inhalable forms of medical cannabis, which can offer relief faster than alternate forms of the drug. “The oral forms were taking one to two hours, sometimes four hours, to have an effect,” Newton said. “Some people’s conditions, we heard from patients, need some relief more rapidly than that, and so the inhalation version takes care of that.” Smoking and public consumption of cannabis will still be outlawed under the bill, he added, as will products like candy and edibles. The bill also expands the list of qualifying health conditions, adding Lupus, severe arthritis and severe insomnia, and removing the requirement that certain diagnoses like cancer or Parkinson’s disease be “severe or end stage.” Rep. Alan Powell, a Hartwell Republican, also applauded the bill in a speech on the House floor. “This is a natural product,” he said. “I have said this from this well before, and I continue to tell you that something that God lets grow naturally is better than anything made in a pharmaceutical laboratory.” Newton said he hopes to see more medical research on cannabis develop in the coming years if marijuana becomes a Schedule III drug at the federal level. Though no lawmakers spoke against the bill on the floor, some voiced concerns about the lack of current medical evidence to support expanding the program. “I’m for it, I just think that we need to do a little more [research] about it,” said Rep. Jason Ridley, a Chatsworth Republican who voted against the bill. “I’d just like to see a little more parameters put around that exactly what we’re dealing with.” Bills related to medical cannabis and hemp beverages became a focal point during the 2025 session, which also marked the 10-year anniversary of Haleigh’s Hope Act. The law created the licensing commission, legalized possession of low-THC oil for the first time in Georgia and created a new research program dedicated to studying the drug’s impact. Subsequent legislation enabled companies to produce and sell the oil in-state, but advocates have argued that Georgia’s current laws do not go far enough to help patients access medical cannabis in the forms that they need. The bill now heads back to the Senate for another vote. The session is set to end April 2. This story was first published by Georgia Recorder. The post Georgia Lawmakers Pass Bill To Expand Medical Marijuana Access appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Regards for the purpose of post this amazing piece of writing! I recently came across yuor web blog perfect for your preferences. It includes marvelous not to mention advantageous items. Cultivate monetary management give good results! Eu9 Login

I found your this post while searching for some related information on blog search...Its a good post..keep posting and update the information. costs to advertise on google

Thanks for taking the time to discuss this, I feel strongly that love and read more on this topic. If possible, such as gain knowledge, would you mind updating your blog with additional information? It is very useful for me. 해외선물 개발

I found your this post while searching for information about blog-related research ... It's a good post .. keep posting and updating information. 해외선물 분양

To truly experience the essence of love and romance, you should consider hiring call girls in Chandigarh. Despite Chandigarh being a focal point for aesthetics, many individuals do not have the chance to enjoy the city's charm. Chandigarh call girls will offer you a private guide to the city’s most captivating attractions and can also give you tips on how to partake in sexual activities. Chandigarh Call Girl || Call Girl in Chandigarh

Virginia House and Senate lawmakers have reached a deal on a final bill to legalize recreational marijuana sales in the commonwealth. While both chambers approved companion versions of the cannabis legislation this session, with amendments adopted along the way that more closely aligned them, there were still key outstanding differences to resolve after the latest votes earlier this month. Among the key areas of dispute were the start date for adult-use sales, the proposed tax rate on marijuana and what agency would be responsible for regulating the market. Following bicameral negotiations in a conference committee, lawmakers arrived at a consensus and released the final bill on Friday. Shortly thereafter, the Senate voted 21-18 to approve the deal. The House of Delegates is expected to vote to send it to Gov. Abigail Spanberger (D) by the scheduled end of the session on Saturday. “This conference report reflects months of collaboration and negotiation among legislators, regulators, industry representatives, advocates and public safety stakeholders,” Sen. Lashrecse Aird (D), the bill’s Senate sponsor, said on the floor. “Many parties did not get everything they asked for, but everyone got what they needed to legally and safely operate a marketplace. This is the hallmark of a good compromise, and this legislation represents a balanced path forward to responsibly regulate Virginia’s cannabis market.” Under the new agreement, members landed on January 1, 2027 for the launch date of adult-use marijuana sales, as included in the Senate bill. The House had previously proposed starting sales on November 1, 2026. Cannabis would be subject to an excise tax of 6 percent as well as a 5.3 percent retail sales and use tax, while allowing municipalities to set a local tax of up to 3.5 percent, which is what the House had passed as compared to a higher overall rate proposed by the Senate. With respect to regulatory control, the existing Cannabis Control Authority (CCA) would be tasked with overseeing the program, facilitating licensing and more. The Senate had suggested merging CCA with the Alcoholic Beverage Control Authority into a new agency called the Alcoholic Beverage and Cannabis Control Authority (ABC), but the bicameral agreement simply mandates a study into the idea of giving ABC a role in marijuana regulation. One new item in the final agreement that wasn’t contemplated in either the House or Senate legislation concerns hemp, with lawmakers agreeing to have authority for its regulation transferred to CCA from the Department of Agriculture and Consumer Services. Both chambers’ original marijuana sales proposals, sponsored by Aird and Del. Paul Krizek (D), aimed to give adults a legal means of buying cannabis, the possession and home cultivation of which was legalized in the state in 2021. Here are the key details of the Virginia marijuana sales legalization legislation, SB 542 and HB 642: Adults would be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. Legal sales could begin on January 1, 2027. There would be an excise tax of 6 percent on cannabis sales as well as a 5.3 percent retail sales and use tax, and municipalities could set an additional local tax of up to 3.5 percent. The Virginia Cannabis Control Authority would oversee licensing and regulation of the new industry, and would also take on oversight of hemp, which is currently under the Department of Agriculture and Consumer Services. Revenue would be distributed to the Cannabis Equity Reinvestment Fund (30 percent), early childhood education (40 percent), the Department of Behavioral & Developmental Health Services (25 percent) and public health initiatives (5 percent). Local governments could not opt out of allowing marijuana businesses to operate in their area. Delivery services would be allowed. Serving sizes would be capped at 10 milligrams THC, with no more than 100 mg THC per package. Existing medical cannabis operators could enter the adult-use market if they pay a licensing conversion fee that is set at $10 million. Cannabis businesses would have to establish labor peace agreements with workers. A legislative commission would be directed to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations. It would also investigate the possibility of the Virginia Alcoholic Beverage Control Authority becoming involved in marijuana regulations and enforcement. Prior to the Senate’s passage of its version of the marijuana sales bill, members clashed in committee about amendments that would have added new penalties for illegal cannabis activity. The proposed changes at issue from the Courts of Justice Committee included penalties for consumers who buy from unlicensed sources, the recriminalization of cannabis possession by people under 21 and making sales a class 1 misdemeanor for a first offense and a crime punishable by mandatory jail time for a second offense. As revised, the bill would have also raised the penalty for unlicensed cultivation to a felony punishable by up to five years in jail and made it a felony to transport with intent to distribute cannabis across state lines. But the Finance and Appropriations Committee reversed the amendments last month amid pressure from a coalition of advocacy groups that sent a letter to senators saying they undermined the “intent” of the legislation and the “will of the people” by adding criminal penalties for certain cannabis-related activity. Overall, both chambers’ commercial sales bills have largely aligned with recommendations released in December by the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, certain GOP members have found themselves ideologically aligned with their Democratic colleagues throughout this legislative process, breaking with the majority of their caucus in support of creating a regulated marketplace for adults to purchase cannabis. Since legalizing cannabis possession and home cultivation in 2021, Virginia lawmakers have worked to establish a commercial marijuana market—only to have those efforts consistently stalled under former Gov. Glenn Youngkin (R), who twice vetoed measures to enact it that were sent to his desk by the legislature. Spanberger, for her part, supports legalizing adult-use marijuana sales. Meanwhile, Virginia lawmakers last week passed a bill to protect the rights of parents who use marijuana in compliance with state law, sending it to the governor’s desk. Legislators have additionally sent the governor a measure to provide a pathway to resentencing for people with prior marijuana convictions. Legislation to allow patients to access medical cannabis in hospitals is also set for Spanberger’s action. Photo courtesy of Philip Steffan. The post Virginia Lawmakers Reach Deal On Final Bill To Legalize Recreational Marijuana Sales appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

With Massachusetts voters potentially facing a November ballot initiative to roll back the state’s recreational marijuana law, a new report from officials finds legalization is achieving one of its primary goals: disrupting illicit cannabis sales as adults transition to the regulated market. The report from the Cannabis Control Commission (CCC), released on Friday, found that, among adults who reported past-year marijuana use, an overwhelming 84 percent said they obtained their cannabis from a licensed source. “Consumers of legal age are overwhelmingly turning away from unregulated sources as the state’s adult-use marijuana industry reaches its eighth year in operation,” a CCC press release about the report says. With more than $9 billion in gross sales since the adult-use market launched in 2018, that data point signals that illicit sales are taking a major hit—a policy impact advocates worked to drive home as they built support for legalization. The analysis—which also looked at usage trends, self-reported health benefits, public opinion on legalization and more—involved interviews with 11,635 Massachusetts residents aged 16-65. (State law prohibits recreational cannabis sales for those under 21, but CCC included younger people in the survey to understand trends within that cohort, t0o.) “This new research shows that Massachusetts residents turn away from the illicit market when safe, well-regulated options are available,” CCC Executive Director Travis Ahern said in a press release. “We will continue to monitor sources like the [International Cannabis Policy Study, or ICPS] to guide our mission of overseeing an effective, equitable cannabis marketplace in Massachusetts.” The Massachusetts Cannabis Control Commission has released a new research report measuring recent cannabis use trends in the Commonwealth, revealing that consumers of legal age are overwhelmingly turning away from unregulated sources. Learn more: https://t.co/uue7oO2HZf pic.twitter.com/5KBIvGWjZu — Massachusetts Cannabis Control Commission (@MA_Cannabis) March 13, 2026 Here are some other takeaways from the report: Nearly half of cannabis consumers (43 percent) said they used it to “manage or improve mental health.” The frequency of cannabis use “generally increased year-of-year for every age group 16-20, where it dropped from 2019 to 2023.” People were most likely to report using marijuana flower products (70 percent) compared to other product categories. Overall, 81 percent said they supported adult-use legalization based on the 2023 survey data, which marked a “slight drop from the 83 percent support in the 2022 wave.” “Our new analysis of ICPS data provides valuable insight into use patterns and the level of education around cannabis use,” CCC Chief of Research Julie Johnson said. “We are also making recommendations to help strengthen future data analysis and collection, including partnering on future research with other regulators and public health professionals and asking for the initiation of more comprehensive studies assessing cannabis-related impaired driving and health care usage,” she said. “We also encourage more resources go toward public awareness and youth education, with ample funding available for appropriation through tax revenue generated by cannabis sales.” The fact that 81 percent of Massachusetts resident said they backed legalization in the latest survey raises questions about the prospects of the anti-cannabis initiative gaining the majority supported needed for passage at the ballot in November. A separate poll released earlier this month that specifically asked residents about their position on the rollback measure found that 63 percent are opposed to it, including 48 percent who said they’re “strongly” opposed. Just 20 percent of respondents said they’re in favor of the proposed initiative, with 11 percent “strongly” supportive of the repeal. That survey came months after cannabis activists filed a complaint with the State Ballot Law Commission under the Secretary of State’s office, alleging that petitioners with the anti-cannabis campaign used misleading tactics to convince voters to support its ballot placement. The commission rejected the complaint in January, however, and said advocates who challenged the ballot measure raised “unsupported allegations” about the propriety of the signature gathering process that they said warranted official scrutiny. That decision represented a setback for advocates and industry stakeholders who have flagged numerous accounts of alleged misconduct by petitioners working on behalf of the Coalition for a Healthy Massachusetts. It also came as separate polling found that nearly half of those who signed the marijuana sales repeal petition felt misled, with many claiming that the measure was pitched to them as a proposal to address unrelated issues such as public education and expanded housing. The anti-marijuana coalition has denied any wrongdoing in the signature collection process and waved off the survey results. The initiative would still let adults 21 and older possess and gift up to an ounce of cannabis, but it would repeal provisions of the voter-approved legalization law allowing for commercial sales and home cultivation by adults. The medical cannabis program would remain intact under the measure. An association of state marijuana businesses had separately urged voters to report to local officials if they observe any instances of “fraudulent message” or other deceitful petitioning tactics. Massachusetts Attorney General Andrea Campbell’s (D) office—which cleared the campaign for signature gathering in September—has stressed to voters the importance of reading the summary, which is required to go at the top of the signature form, before signing any petitions. The Massachusetts legislature received the initiative for consideration earlier this month when the 2026 session kicked off. Now that the state election commission has issued its ruling on the complaint, lawmakers have until May 5 to act on the proposal. If they choose not to enact it legislatively, the campaign would need to go through another round of petitioning and get at least 12,429 certified signatures by July 1 to make the November ballot. Meanwhile, the head of Massachusetts’s marijuana regulatory agency recently suggested that the measure to effectively recriminalize recreational cannabis sales could imperil tax revenue that’s being used to support substance misuse treatment efforts and other public programs. Massachusetts lawmakers also recently assembled a bicameral conference committee to reach a deal on a bill that would double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market. In December, state regulators also finalized rules for marijuana social consumption loungues. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — CCC recently launched an online platform aimed at helping people find jobs, workplace training and networking opportunities in the state’s legal cannabis industry. State lawmakers have also been considering setting tighter restrictions on intoxicating hemp-derived products and a plan to allow individual entities to control a larger number of cannabis establishments. Also in Massachusetts, legislators who were working on a state budget butted heads with CCC officials, who’ve said they can’t make critical technology improvements without more money from the legislature. Massachusetts lawmakers additionally approved a bill to establish a pilot program for the regulated therapeutic use of psychedelics. And two committees have separately held hearings to discuss additional psilocybin-related measures. Photo courtesy of Brian Shamblen. The post As Massachusetts Marijuana Legalization Rollback Nears Ballot, New State Report Shows Regulated Market Reaching Most Consumers appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The New Hampshire House of Representatives has effectively killed bills to legalize marijuana and allow the therapeutic use of psilocybin by not bringing them up for floor votes ahead of a key deadline. Meanwhile, separate legislation on those topics has already advanced. As legislators continue to push for a variety of drug policy reform proposals, with mixed results so far this session, the House on Thursday adjourned without bringing up scheduled measures to let voters decide on adult-use marijuana legalization as well as separate bills to end prohibition of low-level cannabis possession and give adults access to psilocybin as a novel treatment alternative. Here’s an overview of the cannabis and psychedelics bills that were not considered by the House: CACR 19 The House failed to consider a bill from Rep. Jonah Wheeler (D) that would have put a constitutional amendment on the state ballot to let voters decide if they want to legalize marijuana for adults 21 and older, allowing them to “possess a modest amount of cannabis for their personal use.” If enacted, the constitutional amendment would have appeared on the November state ballot. The the text of what would have gone before voters on the November ballot under CACR 19 reads: “Are you in favor of amending the first part of the constitution by inserting after article 2-b a new article to read as follows: [Art.] 2-c. [Adult possession of cannabis.] All adults who are 21 years of age or older shall have the right to possess a modest amount of cannabis intended for their personal consumption.” Members of the House Criminal Justice and Public Safety Committee took up that legislation in January. It was ultimately deemed inexpedient to legislate by a majority of the panel, but in New Hampshire all bills still have the opportunity to advance to the floor even with negative committee recommendations. A motion from Rep. Alissandra Murray (D) to special order the legislation for consideration by the body before its adjournment on Thursday failed by a vote of 115-220. In a minority report, Murray, clerk of the committee, wrote that the legislation “returns the question of cannabis legalization to the people of New Hampshire, where it belongs. It does not itself legalize cannabis; rather, it allows voters to decide whether adults age 21 and over may legally possess a modest amount.” “The amendment intentionally avoids specifying possession limits, recognizing that such details are better addressed in statute than embedded in the constitution, where they are more difficult to amend,” she said, adding that polling shows overwhelming public support for legalization in New Hampshire. “It is high time we respect the will of the people and end the continued criminalization of adults for conduct that a strong majority no longer believes should be a crime.” Rep. Terry Roy (R), chair of the panel, wrote in the majority report that the panel “recommends CACR 19 as inexpedient to legislate because embedding a federal crime into the New Hampshire Constitution is a reckless act of legal entrapment that endangers the very liberties we are sworn to protect. While some frame this as ‘respecting the will of the people,’ they are actually inviting Granite Staters into a ‘federal trap’ where exercising a state-granted ‘right’ results in the automatic and permanent forfeiture of their Second Amendment rights.” “Beyond the constitutional risk, we must consider the professional doors this closes: any use authorized by this amendment remains an automatic disqualifier for federal security clearances in New Hampshire’s high-paying defense sector, as well as for military service and law enforcement,” he said. “A truly pro-liberty stance requires protecting our citizens from federal overreach, not baiting them into a conflict that strips them of their right to bear arms and their economic future.” HB 1235-FN Another cannabis legalization bill that didn’t get a floor vote in the House on Thursday is HB 1235-FN from Rep. Jared Sullivan (D) and five bipartisan cosponsors. The measure was also designated as inexpedient to legislate by the Criminal Justice and Public Safety Committee. Under the legislation, HB 1235, adults 21 and older would have been allowed to possess up to 2.5 ounces of cannabis flower and up to 10 grams of marijuana concentrates. The proposal would not have created a system of regulated commercial sales, however. In the majority report from the committee, the chairman reiterated his belief that legalization supporters are mischaracterizing the reform as a personal liberties issue. “The promise of ‘personal freedom’ is a hollow one when it results in the systematic closing of doors for New Hampshire’s young people and the erosion of our fundamental constitutional rights,” Roy said. “We must look at actual outcomes: since legalization, neighboring states have seen a 15 percent increase in workers’ compensation claims and a 55 percent higher rate of industrial accidents among users, a trend that would cripple New Hampshire’s productivity and drive up insurance costs for small businesses.” “Most critically, this bill creates a devastating ‘federal trap’ for the thousands of Granite Staters employed by our state’s thriving defense sector, which remains a primary economic driver with average annual wages exceeding $111,000,” he said. “We refuse to trade New Hampshire’s safety, economic future, and the Second Amendment rights of our citizens for a policy that offers only the illusion of liberty while stripping away the keys to a successful future and increasing road fatalities by 17.3 percent as seen in our neighboring states.” Rep. Buzz Scherr (D) said in the committee’s minority report that the proposed legislation “recognizes that New Hampshire residents are notably in favor of such an approach and that all of New Hampshire’s surrounding states have taken some version of this approach.” Sullivan, the bill sponsor, also filed separate legislation this session that would have legalized adult-use cannabis through a regulated sales model, with additional provisions to provide relief for those who’ve previously been criminalized over marijuana. That bill already passed the House this year, but it was then promptly killed in the Senate. HB 1796-FN The House on Thursday also did not take up a Republican-led bill from Rep. Michael Moffett (R) that would have permitted the regulated use of psilocybin in a medically supervised setting. To qualify for psilocybin treatment, a patient 21 or older would have needed to be diagnosed with treatment-resistant depression, PTSD, substance misuse disorder, a terminal illness requiring end-of-life care or any other condition authorized by the state Department of Health and Human Services (DHHS). There would have been specific guidelines for facilities where the psychedelic could be administered, including security requirements and other safety protocols such as ensuring there are rescue medications on site if a patient experiences an adverse event. The legislation, HB 1796, would have also established a Therapeutic Psilocybin Treatment Fund, which would have been funded by revenue from licensing taxes and fees. The fund would have gone toward studies into the possibility of expanding the program to include additional psychedelics in the program. Rep. Tim Hartnett (D)—on behalf of the majority of the House Health, Human Services and Elderly Affairs Committee that deemed the psilocybin bill inexpedient to legislate—said in a report that the measure contains “several insurmountable challenges,” including “significant financial challenges in staffing and related costs” for DHHS. “Second, the bill presupposes existing expertise and related capacities already exist within the NH government,” the report says. “Third, psilocybin has great promise and even though significant anecdotal evidence exists on its therapeutic benefit, compelling confirmatory scientific evidence remains early in its development.” “Further, beyond scientific studies, the experience of actual day-to-day-mainstream clinic operations are even less well understood—the ‘how do we run a clinic’ questions of staff recruitment and training, program admissions, management of patient emergencies etc.—are in their infancy. News reports from other jurisdictions suggest there is much to be learned about running and regulating clinics providing treatments using this medication.” A minority report from Rep. Yury Polozov (R) says the legislation “provides an evidence-based treatment option for patients who have not responded to conventional therapies.” “Emerging research supports psilocybin’s potential benefits for mental health conditions when used in controlled therapeutic settings. The bill promotes public health and harm reduction,” the said. “It offers renewed hope for life to those in crisis, as suicide remains a major cause of death, particularly among veterans who often suffer from treatment-resistant depression and post-traumatic stress disorder.” Last month, the House approved a separate bipartisan bill to legalize the regulated use of psilocybin for medical purposes. It is now scheduled to be considered by the House Finance Committee on Tuesday before a final floor vote later this month that could move it to the Senate. The legislation from Scherr would create a regulatory pathway for patients with certain conditions to access the psychedelic for therapeutic use through a program overseen by DHHS. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, Gov. Kelly Ayotte (R) has already threatened to veto any marijuana legalization bill that reaches her desk, though the constitutional amendment proposal would not require gubernatorial action. The governor said in August that her position on the reform would not change even if the federal government moved forward with rescheduling the plant. Since then, President Donald Trump has directed the attorney general to finalize the process of moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). At a committee meeting last year, Sullivan ultimately made a persuasive argument for advancing his legalization bill, pointing out that the House has repeatedly passed similar legislation and that the chamber should stand its ground, forcing the Senate and governor to again go on record with their opposition to a policy popular among voters. “We know where it’s going to go. Let’s send a virtue signal,” Sullivan said. “Let them be the ones that are pissing off voters who care about this.” In the Senate, the Judiciary Committee in January also took up a bill from Sen. Donovan Fenton (D) that would allow adults over the age of 21 to legally possess up to four ounces of cannabis in plant form and 20 grams of concentrated cannabis products, as well as other products containing no more than 2,000 milligrams of THC. Last June, the New Hampshire Senate voted to scrap compromise legislation that would have lowered the state’s criminal penalty for first-time psilocybin possession while also creating mandatory minimum sentences around fentanyl. As originally introduced, the legislation would have completely removed penalties around obtaining, purchasing, transporting, possessing or using psilocybin, effectively legalizing it on a noncommercial basis. However a House committee amended the bill before unanimously advancing it last March. Image element courtesy of Kristie Gianopulos. The post New Hampshire House Lets Marijuana Legalization And Psilocybin Therapy Bills Die Without A Vote appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Delaware Senate has unanimously approved a bill that would allow terminally ill patients to use medical cannabis in hospitals. After advancing through the Senate Health & Social Services Committee, with a clarifying amendment, the full chamber passed the legislation from Sen. Marie Pinkney (D) in a 21-0 vote on Thursday. It now heads to the House of Representatives for consideration. “The legislation essentially requires our hospitals to allow patients to utilize their medical cannabis in the hospital when they are diagnosed with a terminally ill diagnosis,” Pinkney said on the floor ahead of the vote. “The hospitals worked very well with me in the process of formalizing this legislation, and so we have created a process where the patients are ultimately responsible for the administration and storage of their medical cannabis.” “There’s also language in the bill that makes it so that if for some reason, the federal government decides to react to the fact that cannabis remains scheduled drug that the hospitals are able to put this program on pause so that they won’t be at risk for losing any federal funding,” she said. Under SB 226, patients and their caregivers would be responsible for acquiring and administering medical marijuana, and it would need to be stored securely at all times in a locked container. Smoking or vaping of medical cannabis would be prohibited, so patients would need to consume it via other methods. Healthcare facility officials would need to see a copy of patients’ state medical marijuana registry ID cards, and they would be required to note their use of the drug in medical records. They would also need to “develop and disseminate written policies and procedures for the use of medical marijuana within the health care facility.” Facilities would be able to prohibit medical marijuana use if they determine that such use would have an “adverse impact on the medical care and treatment of the patient or is otherwise contraindicated.” They would also be able to suspend permission to use cannabis if a federal agency such as the U.S. Department of Justice or Centers for Medicare and Medicaid Services takes an enforcement action against such use or “issues a rule, guidance, or otherwise provides notification to health care facilities that expressly prohibits the use of medical marijuana in health care facilities.” The right to use medical cannabis under the bill, SB 226, would not apply to patients who are in the emergency department. Prior to the floor vote, the bill sponsor consulted with Medical Society of Delaware and the Delaware Healthcare Association to craft an amendment, which was adopted in committee, specifying that the legislation applies only to licensed acute care hospitals and not other types of healthcare facilities, and clarifying that patients and caregivers must notify attending physicians of patients’ use of medical cannabis. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Delaware, the Senate in January voted to override the governor’s veto of a bill that would prevent local governments from imposing onerous zoning restrictions that make it more challenging for marijuana businesses to operate in their jurisdictions. Delaware’s adult-use cannabis market launched last August, with the governor touting the state’s first “successful” weekend of adult-use cannabis sales, with total purchases for medical and recreational marijuana totaling nearly $1 million—and compliance checks demonstrating that the regulated market is operating as intended under the law. The launch of Delaware’s legal market came about two years after marijuana legalization was enacted into law under former Gov. John Carney (D). Ahead of the sales roll-out, the governor last July toured one of the state’s cannabis cultivation facilities, praising the quality of marijuana that’s being produced, which he said will be the “French wine of weed.” The launch of the legal market came with some controversy, however, with critics alleging that allowing medical operators to start adult-use sales ahead of other license applicants is unfair. Dozens of other would-be retailers that have either already received licenses or are still awaiting issuance will need to wait for further regulatory approvals until they can open their doors—a situation that’s frustrated some advocates. Two lawmakers who led the push to legalize marijuana sought input from consumers and businesses about the market launch. Sen. Trey Paradee (D), the sponsor of SB 75, and House Majority Whip Rep. Ed Osienski (D)—the primary sponsor of the state’s 2023 legalization bills—put out an online form last year for residents to share thoughts and feedback about the cannabis program anonymously. Separately, a Delaware House committee in January approved a bill to decriminalize public consumption of marijuana. While certain legal marijuana states like Colorado and Ohio still impose criminal penalties for public cannabis use, Delaware stands out as especially punitive, with a maximum penalty that carries the risk of jail time in addition to a fine. The post Delaware Senate Passes Bill To Let Terminally Ill Patients Use Medical Marijuana In Hospitals appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Federal marijuana rescheduling would represent a historic policy change with major implications for cannabis research and industry—but it should be viewed as a “transitional” step that must be followed up with comprehensive reform to better align state and federal law while promoting equity, a new academic paper argues. Professors at the University of California published the analysis in the journal Cannabis & Cannabinoid Research, focusing on the impacts and limitations of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) as federal agencies recommended following a scientific review. To be sure, rescheduling “would be the most significant federal cannabis policy shift in more than five decades, yet its legal and practical consequences are widely misunderstood,” the paper says, noting that the move has the potential to “expand research capacity and strengthen incentives for [Food and Drug Administration, or FDA] compliant development.” But the reform would not federally legalize marijuana or legitimize state cannabis markets, and confusion around the continued legal disconnect could prove problematic as the reform movement continues to expand, it points out. The authors also emphasized that “rescheduling does not expunge records, repair past harms, or ensure equitable participation and may accelerate consolidation absent protective safeguards.” “We conclude that Schedule III should be treated as a transitional status, with agencies prioritizing research access and public health surveillance while Congress addresses banking, interstate commerce, and durable criminal justice and equity reforms,” the paper says. The analysis—which is based on documentation from federal agencies, reports from the Congressional Research Service (CRS) and independent studies on rescheduling—is broken down into two key sections: What moving cannabis to Schedule III does do, and what it doesn’t do. On a surface level, rescheduling would finally recognize the medical value of marijuana, consistent with the definition of a Schedule III drug. Such substances hold relatively low abuse potential with some currently accepted medical use. As a Schedule I drug, marijuana is currently considered medically useless and uniquely dangerous under federal law. The report also says that “perhaps the most consequential long-term impact of rescheduling is its effect on research,” removing certain barriers associated with studying Schedule I drugs that have deterred scientists from taking on the added costs and logistical requirements to research marijuana. “Rescheduling would also mitigate the chilling effect that Schedule I stigma has had on academic and clinical participation, thereby enabling broader institutional engagement,” the authors said. “Recent executive actions directing federal agencies to prioritize medical cannabis and cannabidiol research reinforce this shift.” Another impact of rescheduling is that, while it wouldn’t mean automatic FDA approval of cannabis products available in state markets across the country, it would clarify “regulatory incentives for product development.” The paper also explains that “one of the most immediate commercial effects of rescheduling would be relief” from the Internal Revenue Service (IRS) code known as 280E, which currently prevents state-licensed cannabis businesses from taking federal tax deductions that are available to other traditional industries. “This shift would improve reinvestment capacity, debt service, and financial stability for many operators,” the authors said. “However, increased capital availability may also accelerate consolidation if effective equity-protective measures are not put in place. This dynamic could have negative public health consequences, as the history of tobacco use suggests.” Rescheduling would not mean that marijuana would be federally legalized, the paper stresses, nor would it allow for interstate marijuana commerce or “confer FDA approval on existing products.” “State-legal cannabis would remain federally unlawful unless specific statutory exemptions or FDA approval pathways are in place,” it says. “Banking access would remain constrained without congressional action, such as the enactment of the SAFE or SAFER Banking Act, which would provide statutory protections allowing banks and credit unions to offer financial services to state-legal cannabis businesses without exposure to federal penalties. These limitations reflect structural features of federal law rather than regulatory oversight.” Further, rescheduling “does not resolve the legal paradox in state markets: compliance with state law does not guarantee federal legality,” it continues, stating that the resulting tension “may persist for years, underscoring the need for legislative clarity.” As many advocates have explained, moving marijuana to Schedule III on its own also “does not advance social equity,” despite the fact that criminalization “has inflicted significant harm on disadvantaged communities through arrests, convictions, and collateral consequences.” “Although rescheduling acknowledges medical use, it does not expunge records, repair past harms, or ensure equitable participation in legal markets,” the paper says. “Sequencing reforms to include targeted capital access, technical assistance, and protections against predatory acquisitions is essential.” “Federal agencies should treat Schedule III as a transitional status. Priorities should include expanding research access, strengthening public health surveillance, and protecting equity operators. Congress retains responsibility for resolving issues related to interstate commerce, banking, and criminal justice reform. Reform sequencing should explicitly guard against displacement caused by consolidation.” “Rescheduling cannabis to Schedule III would mark a historic recalibration of federal drug policy. It aligns statutory classifications with contemporary medical evidence without legalizing cannabis, approving products, or resolving equity concerns,” the authors conclude. “Properly understood, Schedule III is a starting point—an opportunity to replace absolute declarations with evidence and to pursue a coherent, equitable cannabis policy grounded in science and law.” What the paper doesn’t address is the current rulemaking status of the rescheduling proposal, which resulted from a review mandate under the Biden administration. President Donald Trump subsequently signed an executive order in December that directed the attorney general to expeditiously finalize the rescheduling process, but that’s yet to materialize. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, the first-ever White House drug czar recently said that while he loves Trump and “almost everything he does,” that affection doesn’t extend to the pending proposal to federally reschedule marijuana, which he described as a “gateway drug” that’s harming youth. A White House spokesperson defended the administration’s rescheduling push in an earlier interview with Fox News Digital, stating that it’s part of his “pledge to expand medical research into applications of marijuana and cannabidiols.” “The president’s historic action paved the way for the development of promising new treatments for American patients, especially veterans—and the presence of several leaders from law enforcement and veterans groups at the Oval Office signing is indicative of how President Trump continues to push the envelope to support our nation’s heroes,” White House spokesperson Kush Desai said. The rescheduling plan has been met with mixed reactions on Capitol Hill. For example, prohibitionist Rep. Andy Harris (R-MD) half-jokingly told Marijuana Moment last month that he felt the Justice Department should “take about 20 years” to finish the rescheduling process. In December, Harris separately said Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. Another GOP lawmaker on the other side of the debate, Congressional Cannabis Caucus co-chair Rep. Dave Joyce (R-OH), recently told Marijuana Moment that while marijuana rescheduling might not be at the top of the agenda for the Justice Department or White House amid competing interests, he and bipartisan colleagues will be ready when “opportunity does present itself.” Joyce separately said in January that he doesn’t think the attorney general would seek to undermine the president’s executive order to move marijuana to Schedule III despite any personal reservations she may have about the policy change. Former Rep. Matt Gaetz (R-FL), Trump’s first pick for attorney general this term who ultimately withdrew his nomination, raised eyebrows after posting on X that he’s been told the Drug Enforcement Administration (DEA) is actively drafting a rescheduling rule and intended to issue it “ASAP.” There’s some confusion around that point, however, as a rule is already pending before the Justice Department—and a new rule would presumably be subject to additional administrative review and public comment. A Democratic senator told Marijuana Moment in January that it’s “too early to tell” what the implications of Trump’s cannabis order would be—saying that while there are “things that look promising” about it, he is “very concerned about where the DOJ will land.” “The ability of the Trump administration to speak out of both sides of their mouth is staggering,” Sen. Cory Booker (D-NJ) said. “So I’m just going to wait and see right now. Obviously, there’s things that look promising—to end generations of injustice. I really want to wait and see.” In January, two GOP senators filed an amendment to block the Trump administration from rescheduling cannabis, but it was not considered on the floor. Meanwhile, DEA recently said the cannabis rescheduling appeal process “remains pending” despite Trump’s executive order. Bondi, the attorney general, separately missed a congressionally mandated deadline in January to issue guidelines for easing barriers to research on Schedule I substances such as marijuana and psychedelics. Photo courtesy of Chris Wallis // Side Pocket Images. The post Marijuana Rescheduling Is A ‘Transitional’ Step That Must Be Followed By Banking, Commerce And Justice Reforms, New Analysis Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Bipartisan congressional lawmakers have filed a bill that would repeal a decades-old federal statute that’s led to the denial of housing for millions of people with prior drug convictions. Reps. Maxwell Alejandro Frost (D-FL) and Ryan Mackenzie (R-PA) filed the legislation—titled the “Fair Future Act”—last week. An earlier version was introduced with a Senate companion last session, but it did not advance to enactment. The measure would strike a section of the 1988 Fair Housing Amendments Act that the lawmakers say has prevented more than nine million people from accessing rental housing no matter how serious the offense was or how long it’s been since they’ve been convicted. “Because drug laws vary widely from state to state, this policy can produce dramatically different outcomes for Americans living just miles apart,” a press release from Frost’s office says. “In one state, a person may serve jail time for marijuana possession and then face permanent exclusion from federal Fair Housing protections. Across the state line, however, the same conduct may be entirely legal.” Frost said that “housing is a fundamental human right and the foundation for a stable and dignified life.” “People who have served their time and repaid their debt to society should be no exception. Outdated housing policies and conflicting state laws deny those with prior drug convictions a fair shot at reentering society,” he said. “At the same time, the criminalization of homelessness only deepens the cycle of instability, setting people up to fail before they have a chance to rebuild. The Fair Future Act will help break this cycle of exclusion and ensure that a past mistake does not erase a person’s right to a safe, stable place to call home.” Mackenzie, for his part, said that fair housing access “is fundamental to the American Dream,” and, for many Americans, the current statute “has become an insurmountable obstacle.” “By allowing housing providers to automatically reject some applicants based on certain past drug convictions, regardless of how much time has passed, the law can shut the door on individuals who have worked to rebuild their lives,” the congressman said. “It’s time to give every American equal opportunity when applying for a lease.” Sen. Cory Booker (D-NJ) filed the Senate companion of the Fair Future Act in 2024. It remains to be seen whether he will lead on the legislation in his chamber this session. Booker and Rep. Eleanor Holmes Norton (D-DC) introduced a separate bill in December to allow people living in federally assisted housing to use marijuana in compliance with state laws without having to fear losing their homes. Under current policy, people who live in public housing are prohibited from using controlled substances in those facilities regardless of state law, and landlords are able to evict them. The bicameral legislation—titled the “Marijuana in Federally Assisted Housing Parity Act”—would change that. Norton has filed similar versions of the proposal over recent sessions, but the reform has yet to be enacted. Booker joined Norton in sponsoring the legislation last Congress as well. In 2018, a Trump administration official said that she was working to resolve conflicting federal and state marijuana laws as it applies to residency in federally-subsidized housing, but it’s not clear what came of that effort. Norton sent a letter to HUD in 2021 that implored the department to use executive discretion and not punish people over cannabis in legal states. In response, the President Joe Biden’s HUD secretary told the congresswoman that it is statutorily required to continue denying federally assisted housing to people who use marijuana, even if they’re acting in compliance with state law. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Rep. Alexandria Ocasio-Cortez (D-NY) also raised the issue during a committee hearing in 2019, pressing former HUD Secretary Ben Carson on policies that cause public housing residents and their families to be evicted for committing low-level offenses such as marijuana possession. Ocasio-Cortez and then-Sen. Kamala Harris (D-CA) also filed legislation that year that would protect people with low-level drug convictions from being denied access to or being evicted from public housing. Sen. Jeff Merkley (D-OR) also introduced an affordable housing bill in 2020 that included a provision to prevent landlords from evicting people over manufacturing marijuana extracts if they have a license to do so. Last week, Merkley filed an amendment to House-passed housing bill with provisions that would allow people who work in the state-legal marijuana industry to qualify for federal mortgage loans. Read the latest version of the Fair Future Act below: The post New Bipartisan Congressional Bill Would Prevent Housing Discrimination Against People Convicted Of Marijuana And Other Drug Offenses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

There is a certain fantasy associated with the grace and sophistication of an airhostess. Our escorts from this profession bring that same level of poise, care, and attention to detail into your private time. They know how to take care of you and ensure your journey into pleasure is smooth and unforgettable. Fulfill that secret fantasy today. Welcome aboard a beautiful Airhostess Escort In Delhi for a first-class experience.